Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers

被引:11
|
作者
Grinshpun, Albert [1 ]
Halpern, Naama [2 ,5 ]
Granit, Roy Zvi [3 ]
Hubert, Ayala [1 ]
Hamburger, Tamar [1 ]
Laitman, Yael [4 ,5 ]
Shacham-Shmueli, Einat [2 ,5 ]
Peerless, Yehudit [1 ]
Friedman, Eitan [4 ,5 ]
Peretz, Tamar [1 ]
机构
[1] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel
[2] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
[3] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Jerusalem, Israel
[4] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Ramat Gan, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
CONSENSUS MOLECULAR SUBTYPES; FOUNDER MUTATIONS; BREAST; RISKS;
D O I
10.1038/s41431-017-0067-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the BRCA1/2 genes were recently shown to be associated with an increased risk for colorectal cancer. We characterized the largest cohort available of BRCA1/2 mutation carriers with colorectal cancer. We analyzed 32 patients with lower gastrointestinal cancers and germline BRCA1/2 mutations from two large academic hospital registries; 91% of patients were of Ashkenazi ancestry, 78% were women, and 62.5% were carriers of BRCA1 gene mutations. A high percentage of colorectal tumors (34.5%) had a mucinous histology and were located atypically in the left colon. Two patients had anal cancer with unusual histology and an additional patient had mucinous small bowel carcinoma. Gene expression analysis showed significant correlation between the gene signatures of left mucinous colorectal cancer and basal-like breast cancer. Our results imply that Ashkenazi BRCA1/2 mutation carriers with colorectal cancer might have unique characteristics with a high rate of left-sided, mucinous histology colorectal cancer, and possibly anal carcinoma. This report suggests a phenotypic influence of defects in DNA repair genes on colorectal tumors.
引用
收藏
页码:382 / 386
页数:5
相关论文
共 50 条
  • [21] Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
    Warner, Ellen
    CANCERS, 2018, 10 (12)
  • [22] Cancer risks among BRCA1 and BRCA2 mutation carriers
    Levy-Lahad, E.
    Friedman, E.
    BRITISH JOURNAL OF CANCER, 2007, 96 (01) : 11 - 15
  • [23] BRCA1 mutation carriers
    Orli Bahcall
    Nature Genetics, 2013, 45 (4) : 352 - 352
  • [24] Increased risk of contralateral breast cancer for BRCA1 mutation carriers compared to BRCA2 mutation carriers
    Graeser, M.
    Engel, C.
    Zaino, M.
    Schmutzler, R.
    ONKOLOGIE, 2008, 31 : 28 - 28
  • [25] Cancer incidence in BRCA1 mutation carriers.
    Thompson, DJ
    Easton, DF
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 387 - 387
  • [26] Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers
    Laitman, Yael
    Michaelson-Cohen, Rachel
    Levi, Einat
    Chen-Shtoyerman, Rakefet
    Reish, Orit
    Ben-Yehoshua, Sagi Josefsberg
    Bernstein-Molho, Rinat
    Keinan-Boker, Lital
    Rosengarten, Ora
    Silverman, Barbara G.
    Perri, Tamar
    Korach, Jacob
    Mor, Pnina
    Ben-Baruch, Noa Ephrat
    Lahad, Ephrat Levy
    Friedman, Eitan
    CANCER, 2019, 125 (05) : 698 - 703
  • [27] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Kelly Metcalfe
    Henry T. Lynch
    Parviz Ghadirian
    Nadine Tung
    Charmaine Kim-Sing
    Olufunmilayo I. Olopade
    Susan Domchek
    Andrea Eisen
    William D. Foulkes
    Barry Rosen
    Danny Vesprini
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2011, 127 : 287 - 296
  • [28] Aspirin and breast cancer risk for BRCA1 and BRCA2 mutation carriers
    Kornhauser, Naomi
    Terry, Mary Beth
    Vahdat, Linda T.
    Andrulis, Irene
    Buys, Saundra
    Daly, Mary
    John, Esther
    Hopper, John L.
    Cigler, Tessa
    CANCER RESEARCH, 2015, 75
  • [29] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    K Metcalfe
    S Gershman
    H T Lynch
    P Ghadirian
    N Tung
    C Kim-Sing
    O I Olopade
    S Domchek
    J McLennan
    A Eisen
    W D Foulkes
    B Rosen
    P Sun
    S A Narod
    British Journal of Cancer, 2011, 104 : 1384 - 1392
  • [30] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    M Ahmed
    F Lalloo
    A Howell
    DG Evans
    Breast Cancer Research, 12